PMC3114615_01
Metastatic hepatic lesion in segment 3 measuring 38 mm before treatment with sunitinib. April 2009.
cro0004-0055-f01.jpg
PMC3114615_01_cro0004-0055-f01.jpg
F1
After 4 months of monitoring, a CAT re-evaluation was performed, and the diameter of the irradiated paravertebral lesion had decreased by 50%, while the hepatic lesions had enlarged to 38 and 25 mm, respectively (fig. 1).
Metastatic hepatic lesion in segment 3 measuring 30 mm after treatment with sunitinib. May 2010.
cro0004-0055-f02.jpg
PMC3114615_01_cro0004-0055-f02.jpg
F2
The image tests carried out from the start of anti-VEGFR treatment in June 2009 until September 2010 revealed disease stabilisation (fig. 2) in the liver and head.